BioCentury
ARTICLE | Company News

Echo Therapeutics diagnostic news

November 24, 2014 8:00 AM UTC

Echo engaged PricewaterhouseCoopers LLP to explore financial and strategic alternatives, which could include sale of assets, merger, capital transaction or petition for bankruptcy. In September, Echo suspended its operations to conserve liquidity and capital resources (see BioCentury, Oct. 6). ...